AC Immune SA (ACIU)
2.45
+0.05
(+2.08%)
USD |
NASDAQ |
Oct 15, 16:00
2.45
0.00 (0.00%)
After-Hours: 20:00
AC Immune Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | -86.66M |
| September 30, 2025 | -60.02M |
| June 30, 2025 | -48.45M |
| March 31, 2025 | 52.94M |
| December 31, 2024 | 75.04M |
| September 30, 2024 | 51.10M |
| June 30, 2024 | 48.18M |
| March 31, 2024 | -48.76M |
| December 31, 2023 | -68.09M |
| September 30, 2023 | -68.27M |
| June 30, 2023 | -66.55M |
| March 31, 2023 | -69.42M |
| December 31, 2022 | -76.31M |
| September 30, 2022 | -77.22M |
| June 30, 2022 | -78.77M |
| March 31, 2022 | -77.17M |
| December 31, 2021 | -71.26M |
| September 30, 2021 | -74.32M |
| June 30, 2021 | -77.01M |
| March 31, 2021 | -74.98M |
| Date | Value |
|---|---|
| December 31, 2020 | -65.85M |
| September 30, 2020 | -56.80M |
| June 30, 2020 | -20.52M |
| March 31, 2020 | -20.42M |
| December 31, 2019 | 55.77M |
| September 30, 2019 | 57.51M |
| June 30, 2019 | 27.33M |
| March 31, 2019 | 36.00M |
| December 31, 2018 | -44.26M |
| September 30, 2018 | -25.68M |
| June 30, 2018 | -21.91M |
| March 31, 2018 | -24.62M |
| December 31, 2017 | -22.38M |
| September 30, 2017 | -36.49M |
| June 30, 2017 | -19.47M |
| March 31, 2017 | -9.750M |
| December 31, 2016 | -5.640M |
| September 30, 2016 | -5.676M |
| June 30, 2016 | 20.04M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Precigen, Inc. | -114.16M |
| Basilea Pharmaceutica AG | 75.01M |
| Santhera Pharmaceuticals Holding AG | -0.7361M |
| Aldeyra Therapeutics, Inc. | -22.02M |
| BeOne Medicines Ltd. | 1.488B |